News und Analysen
NIKE, Inc. Declares $0.40 Quarterly Dividend
NIKE, Inc. (NYSE: NKE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.40 per share on the Company’s outstanding Class A and Class B Common Stock payable on
Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2024.
Fourth Quarter 2024 Financial Highlights:
-
Revenue grew 8%
Coinbase Releases Fourth Quarter and Full Year 2024 Shareholder Letter
Coinbase Global, Inc. (the “Company” or “Coinbase”) has posted a shareholder letter containing its fourth quarter and full year 2024 financial results on its Investor Relations website at investor.
D.R. Horton, Inc. to Present at the Barclays 42nd Annual Industrial Select Conference on February 19, 2025
D.R. Horton, Inc. (NYSE:DHI), America’s Builder, announced that the Company will present to the investment community via webcast at the 2025 Barclays 42nd Annual Industrial Select Conference on
D.R. Horton, Inc. to Release 2025 Second Quarter Earnings on April 17, 2025
D.R. Horton, Inc. (NYSE:DHI), America’s Builder, announced today that the Company will release financial results for its second quarter ended March 31, 2025 on Thursday, April 17, 2025 before the
Verisign Announces the Retirement of George E. Kilguss III, Executive Vice President and Chief Financial Officer
VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that after 13 years with the Company, George E. Kilguss III
Turkiye Garanti Bankasi A.S.: Coupon Rate of Subordinated Debt Securities to Qualified Investors
Humana and Monogram Health Announce Expansion of Comprehensive Kidney Care Program
Humana and Monogram Health are pleased to announce a significant expansion, extending member access to in-home treatment for kidney disease and its underlying causes. Eligible Humana Medicare
Pfizer’s TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer
Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Walmart To Host Fourth Quarter Earnings Conference Call February 20th, 2025
Walmart Inc. (NYSE: WMT) announced it will hold a live conference call with the investment community at 7 a.m. CST on Thursday, Feb. 20, 2025, to discuss the company's fourth quarter and full-year
CRH Announces Date for Q4 and Full Year 2024 Results Conference Call
CRH (NYSE: CRH), the leading provider of building materials solutions, will publish its fourth quarter and full year 2024 financial results after the U.S. market closes on Wednesday, February 26
Howmet Aerospace Reports Fourth Quarter and Full Year 2024 Results
Howmet Aerospace (NYSE:HWM):
Fourth Quarter 2024 GAAP Financial Results
-
Revenue of $1.9 billion, up 9% year over year, driven by Commercial Aerospace, up 13%
-
Net Income of $314 million
Eaton announces live webcast of investor conference on March 11, 2025
Intelligent power management company Eaton (NYSE:ETN) today announced it will host its 2025 investor conference on Tuesday, March 11, 2025, from 2 p.m. to 5:30 p.m. Eastern time. The purpose of the
Copart, Inc. to Release Second Quarter Fiscal 2025 Results
Copart, Inc. (NASDAQ: CPRT) announced today that it will release earnings for the second quarter of fiscal 2025 after 4:00 p.m. Eastern Time (3:00 p.m. Central) on Thursday, February 20, 2025.
QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and
Ventas Reports 2024 Full Year Results, Provides 2025 Outlook and Increases Dividend
Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the full year and fourth quarter ended December 31, 2024.
CEO Remarks
“Ventas delivered strong financial
U.S. FDA Approves Pfizer’s ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in
Philip Morris International to Present at 2025 CAGNY Conference
Regulatory News:
Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast of a presentation by Jacek Olczak, Chief Executive Officer, and Emmanuel Babeau, Chief Financial
Eastman CEO Mark Costa to Address the Barclays Industrial Select Conference
Eastman Chemical Company (NYSE:EMN):
Industrial Select Conference
Mark Costa, Board Chair and Chief Executive Officer, Eastman Chemical Company (NYSE:EMN), will address the Barclays 42nd
Union Pacific Corporation Executives to Address Barclays 2025 Industrial Select Conference
Jim Vena, chief executive officer, Jennifer Hamann, executive vice president and chief financial officer, and Kenny Rocker, executive vice president – Marketing & Sales, of Union Pacific
ServiceNow Launches Government Transformation Suite, Uniting High-Impact Solutions Tailored to Administration Priorities
SERVICENOW FEDERAL FORUM – ServiceNow (NYSE: NOW), the AI platform for business transformation, today launched the new Government Transformation Suite to increase visibility, accelerate ROI, and
New FICO Survey: 88% of Customers Consider Customer Experience of Equal Importance to Product Offerings When Choosing Their Bank
FICO (NYSE: FICO)
Highlights:
-
A new FICO survey finds that 88% of bank customer respondents report that customer experience is as important or more important than its products and services
Exelon Reports Fourth Quarter and Full Year 2024 Results and Initiates 2025 Financial Outlook
Exelon Corporation (Nasdaq: EXC) today reported its financial results for the fourth quarter and full year 2024.
"I am pleased to announce Exelon has delivered against our financial goals for



